Apremilast reduces axial inflammation in patients with Psoriatic Athritis as assessed by Canden MRI scoring: Results from the Phase 4 MOSAIC Study

Mikkel Østergaard; Walter P.  Maksymowych; R G  Lambert; M Boesen; Guillermo Valenzuela; M Bubb; Olga Kubassova; X Baraliakos; Carlo Selmi; Stephen Colgan; C. Klyachkin; Cynthia Deignan; Zhou Zhou; P. J.  Mease

Apremilast reduces axial inflammation in patients with Psoriatic Athritis as assessed by Canden MRI scoring: Results from the Phase 4 MOSAIC Study

Mikkel Østergaard
, Walter P. Maksymowych
, R G Lambert
, M Boesen
, Guillermo Valenzuela
, M Bubb
, Olga Kubassova
, X Baraliakos
, Carlo Selmi
, Stephen Colgan
, C. Klyachkin
, Cynthia Deignan
, Zhou Zhou
, P. J. Mease

Originalsprog	Engelsk
Publikationsdato	2024
Status	Udgivet - 2024
Begivenhed	EULAR 2024: European Congress of Rheumatology - Wien, Østrig Varighed: 12 jun. 2024 → 15 jun. 2024

Konference

Konference	EULAR 2024
Land/Område	Østrig
By	Wien
Periode	12/06/2024 → 15/06/2024

Citationsformater

Østergaard, M., Maksymowych, W. P., Lambert, R. G., Boesen, M., Valenzuela, G., Bubb, M., Kubassova, O., Baraliakos, X., Selmi, C., Colgan, S., Klyachkin, C., Deignan, C., Zhou, Z., & Mease, P. J. (2024). Apremilast reduces axial inflammation in patients with Psoriatic Athritis as assessed by Canden MRI scoring: Results from the Phase 4 MOSAIC Study. Annals of the Rheumatic Disease Volume 83, supplement 1; 707. Abstract fra EULAR 2024, Wien, Østrig.

Apremilast reduces axial inflammation in patients with Psoriatic Athritis as assessed by Canden MRI scoring: Results from the Phase 4 MOSAIC Study. / Østergaard, Mikkel; Maksymowych, Walter P.; Lambert, R G et al.
2024. Annals of the Rheumatic Disease Volume 83, supplement 1; 707 Abstract fra EULAR 2024, Wien, Østrig.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

Østergaard, M, Maksymowych, WP, Lambert, RG, Boesen, M, Valenzuela, G, Bubb, M, Kubassova, O, Baraliakos, X, Selmi, C, Colgan, S, Klyachkin, C, Deignan, C, Zhou, Z & Mease, PJ 2024, 'Apremilast reduces axial inflammation in patients with Psoriatic Athritis as assessed by Canden MRI scoring: Results from the Phase 4 MOSAIC Study', EULAR 2024, Wien, Østrig, 12/06/2024 - 15/06/2024 s. Annals of the Rheumatic Disease Volume 83, supplement 1; 707.

@conference{12001e0238614172a227fa3942be1633,

title = "Apremilast reduces axial inflammation in patients with Psoriatic Athritis as assessed by Canden MRI scoring: Results from the Phase 4 MOSAIC Study",

author = "Mikkel {\O}stergaard and Maksymowych, \{Walter P.\} and Lambert, \{R G\} and M Boesen and Guillermo Valenzuela and M Bubb and Olga Kubassova and X Baraliakos and Carlo Selmi and Stephen Colgan and C. Klyachkin and Cynthia Deignan and Zhou Zhou and Mease, \{P. J.\}",

year = "2024",

language = "English",

pages = "Annals of the Rheumatic Disease Volume 83, supplement 1; 707",

note = "EULAR 2024 ; Conference date: 12-06-2024 Through 15-06-2024",

}

TY - ABST

T1 - Apremilast reduces axial inflammation in patients with Psoriatic Athritis as assessed by Canden MRI scoring: Results from the Phase 4 MOSAIC Study

AU - Østergaard, Mikkel

AU - Maksymowych, Walter P.

AU - Lambert, R G

AU - Boesen, M

AU - Valenzuela, Guillermo

AU - Bubb, M

AU - Kubassova, Olga

AU - Baraliakos, X

AU - Selmi, Carlo

AU - Colgan, Stephen

AU - Klyachkin, C.

AU - Deignan, Cynthia

AU - Zhou, Zhou

AU - Mease, P. J.

PY - 2024

Y1 - 2024

M3 - Conference abstract for conference

SP - Annals of the Rheumatic Disease Volume 83, supplement 1; 707

T2 - EULAR 2024

Y2 - 12 June 2024 through 15 June 2024

ER -